Chromocell Therapeutics Corporation (CHRO) — Defensive Interval Ratio
Chromocell Therapeutics Corporation (CHRO) has a Defensive Interval Ratio of 2 days as of June 2025. Defensive assets of $40.40K (cash $-, short-term investments $-, receivables $40.40K) cover 2 days of daily cash needs of $20.05K/day. See Chromocell Therapeutics Corporation current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Chromocell Therapeutics Corporation Defensive Interval Ratio (2024–2024)
This chart shows how Chromocell Therapeutics Corporation's Defensive Interval Ratio has evolved across 1 annual periods from 2024 to 2024. As of June 2025, the ratio stands at 2 days, meaning defensive assets of $40.40K can fund 2 days of operations without new revenue. See debt-free asset ratio of Chromocell Therapeutics Corporation to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Chromocell Therapeutics Corporation (2024–2024)
The table below presents the year-by-year Defensive Interval Ratio for Chromocell Therapeutics Corporation from 2024 to 2024, covering 1 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see CHRO market cap overview.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 4 days | $40.40K | $11.19K/day | $- | $- | — |